HUE039522T2 - Plazma mikroRNS a végbélrák korai kimutatására - Google Patents

Plazma mikroRNS a végbélrák korai kimutatására

Info

Publication number
HUE039522T2
HUE039522T2 HUE12852462A HUE12852462A HUE039522T2 HU E039522 T2 HUE039522 T2 HU E039522T2 HU E12852462 A HUE12852462 A HU E12852462A HU E12852462 A HUE12852462 A HU E12852462A HU E039522 T2 HUE039522 T2 HU E039522T2
Authority
HU
Hungary
Prior art keywords
detection
colorectal cancer
early colorectal
plasma micrornas
micrornas
Prior art date
Application number
HUE12852462A
Other languages
English (en)
Inventor
I Cos Meritxell Gironella
Salvatella Juan Lozano
I Garangou Antoni Castells
Maria Dolores Giraldez
Original Assignee
Hospital Clinic Barcelona
Centro De Investig Biomedica En Red De Enfermedades Hepaticas Y Digestivas Ciberehd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital Clinic Barcelona, Centro De Investig Biomedica En Red De Enfermedades Hepaticas Y Digestivas Ciberehd filed Critical Hospital Clinic Barcelona
Publication of HUE039522T2 publication Critical patent/HUE039522T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HUE12852462A 2011-10-21 2012-10-20 Plazma mikroRNS a végbélrák korai kimutatására HUE039522T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161550148P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
HUE039522T2 true HUE039522T2 (hu) 2019-01-28

Family

ID=48136439

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE15158185A HUE035614T2 (hu) 2011-10-21 2012-10-20 Plazma mikroRNS a végbélrák korai kimutatására
HUE12852462A HUE039522T2 (hu) 2011-10-21 2012-10-20 Plazma mikroRNS a végbélrák korai kimutatására

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE15158185A HUE035614T2 (hu) 2011-10-21 2012-10-20 Plazma mikroRNS a végbélrák korai kimutatására

Country Status (18)

Country Link
US (6) US20150087525A1 (hu)
EP (2) EP2768986B1 (hu)
JP (2) JP6159727B2 (hu)
KR (2) KR101900872B1 (hu)
CN (2) CN104145024A (hu)
AU (1) AU2012356317B2 (hu)
BR (2) BR112014009643B1 (hu)
CA (1) CA2852850C (hu)
DK (2) DK2944700T3 (hu)
ES (2) ES2662401T3 (hu)
HU (2) HUE035614T2 (hu)
IN (1) IN2015DN01855A (hu)
MX (2) MX357119B (hu)
NO (1) NO3051026T3 (hu)
PL (2) PL2944700T3 (hu)
PT (2) PT2768986T (hu)
RU (2) RU2662975C1 (hu)
WO (1) WO2013093635A2 (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2825522A1 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP4036247B1 (en) 2012-09-04 2024-04-10 Guardant Health, Inc. Methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
WO2015126886A1 (en) 2014-02-18 2015-08-27 Baylor Research Institute Mir-320e and colorectal cancer
KR20240023185A (ko) * 2014-06-13 2024-02-20 도레이 카부시키가이샤 대장암의 검출 키트 또는 디바이스 및 검출 방법
WO2016034715A2 (fr) * 2014-09-05 2016-03-10 Prestizia Methode de prediction de l'evolution clinique du cancer colorectal
CN104313142B (zh) * 2014-10-16 2016-02-03 上海交通大学医学院附属仁济医院 miRNA-30a作为标记分子在制备诊断试剂中的用途
CN104388541B (zh) * 2014-10-21 2017-07-04 复旦大学附属肿瘤医院 miR‑1914*和miR‑1915的用途
CN104372004B (zh) * 2014-12-04 2018-04-27 广东医学院 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用
EP3147370A1 (en) 2015-09-28 2017-03-29 Rheinische Friedrich-Wilhelms-Universität Bonn Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat)
EP3390668A4 (en) 2015-12-17 2020-04-01 Guardant Health, Inc. METHODS OF DETERMINING THE NUMBER OF TUMOR GENE COPIES BY ACELLULAR DNA ANALYSIS
WO2018032062A1 (en) * 2016-08-18 2018-02-22 University Of Technology Sydney Biomarkers of oral, pharyngeal and laryngeal cancers
EP3327135A1 (en) * 2016-11-28 2018-05-30 Advanced Marker Discovery, S.L. In vitro method for identifying colorectal adenomas or colorectal cancer
CN106950370A (zh) * 2017-01-25 2017-07-14 上海市第十人民医院 血液微小核酸大肠癌诊断分子组合
CN107254522A (zh) * 2017-06-09 2017-10-17 中山大学附属第三医院 miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用
CN107236799B (zh) * 2017-06-15 2020-06-09 昆明医科大学第六附属医院 一种肾纤维化miRNA标记物
CN107326092B (zh) * 2017-08-25 2021-07-20 深圳市恩普电子技术有限公司 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒
CN107746886B (zh) * 2017-09-11 2019-10-01 朱伟 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用
WO2019144183A1 (en) * 2018-01-23 2019-08-01 La Trobe University Biomarkers of colorectal cancer
EP3752645A4 (en) 2018-02-14 2022-04-13 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES IN NON-MELANOMA SKIN CANCERS
CN110205367B (zh) * 2018-02-28 2022-06-21 伽蓝(集团)股份有限公司 一种筛选保护皮肤细胞端粒的活性物的方法
CN114438214B (zh) * 2018-06-27 2023-12-22 深圳华大生命科学研究院 结直肠癌肿瘤标志物及其检测方法与装置
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
KR102275465B1 (ko) * 2019-01-18 2021-07-09 사회복지법인 삼성생명공익재단 전이성 대장암 치료물질 스크리닝 방법
US20220145398A1 (en) * 2019-03-11 2022-05-12 The Chinese University Of Hong Kong Mirna markers for colorectal cancer
CN110438227A (zh) * 2019-07-29 2019-11-12 广州中昱医学生物科技有限公司 miR-17-92在结直肠癌诊断中的用途
CN112080568A (zh) * 2020-09-27 2020-12-15 扬州大学 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用
WO2023032452A1 (ja) * 2021-08-31 2023-03-09 国立大学法人大阪大学 2型糖尿病・大腸がんを検査する方法
CN116640862A (zh) * 2021-09-08 2023-08-25 广东积因生物有限公司 引物及试剂盒
CN113981096A (zh) * 2021-11-30 2022-01-28 无锡市疾病预防控制中心 一种用于诊断结直肠癌的血浆miRNA标志物及其应用
WO2023222927A2 (en) 2022-05-20 2023-11-23 Novigenix Sa Biomarkers for colorectal neoplasia

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
GB0415277D0 (en) * 2004-07-07 2004-08-11 Colonix Ltd Apparatus and method for sampling mucosal surfaces
US7939255B2 (en) 2006-07-03 2011-05-10 Catholic University Industry Academy Cooperation Foundation Diagnostic methods for colorectal cancer
WO2008055158A2 (en) * 2006-10-30 2008-05-08 University Of South Alabama Microrna as biomarker in cancer
WO2008054828A2 (en) 2006-11-01 2008-05-08 The Ohio State University Research Foundation Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
KR20100093539A (ko) * 2007-10-30 2010-08-25 베리덱스, 엘엘씨 대장암을 모니터링하는 방법
CN101424640B (zh) * 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
WO2009111643A2 (en) * 2008-03-06 2009-09-11 Asuragen, Inc. Microrna markers for recurrence of colorectal cancer
EP2283161A4 (en) * 2008-05-16 2012-03-28 Veridex Llc METHOD FOR EVALUATING COLORECTAL CANCER AND COMPOSITIONS THEREFOR
WO2010004562A2 (en) 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
CN102301002A (zh) * 2008-11-12 2011-12-28 卡里斯生命科学卢森堡控股有限责任公司 使用外来体来确定表现型的方法和***
US9074206B2 (en) * 2008-11-13 2015-07-07 Fudan University Compositions and methods for micro-RNA expression profiling of colorectal cancer
WO2010126355A1 (en) * 2009-04-29 2010-11-04 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
US20100317533A1 (en) 2009-06-05 2010-12-16 British Columbia Cancer Agency Branch Biomarkers of cancer metastasis
WO2011012136A1 (en) 2009-07-28 2011-02-03 Exiqon A/S A method for classifying a human cell sample as cancerous
CN101988060A (zh) * 2009-07-30 2011-03-23 江苏命码生物科技有限公司 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片
WO2011044541A2 (en) * 2009-10-09 2011-04-14 Baylor Research Institute Identification of micrornas (mirnas) in fecal samples as biomarkers for gastroenterological cancers
WO2011076142A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
WO2011076147A1 (en) 2009-12-24 2011-06-30 Fudan University Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer
CA2787027A1 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Detection of gastrointestinal disorders
TW201207395A (en) * 2010-06-23 2012-02-16 Univ Hong Kong Chinese Micro-RNA markers for colorectal cancer

Also Published As

Publication number Publication date
DK2768986T3 (en) 2018-09-10
BR112014009643A2 (pt) 2017-12-12
EP2944700B1 (en) 2017-10-18
JP2015128442A (ja) 2015-07-16
CN104651521B (zh) 2021-08-27
KR101912731B1 (ko) 2018-10-29
BR112014009643B1 (pt) 2020-12-15
US20160289771A1 (en) 2016-10-06
PL2768986T3 (pl) 2018-12-31
ES2688693T3 (es) 2018-11-06
KR20140097195A (ko) 2014-08-06
ES2662401T3 (es) 2018-04-06
RU2014120427A (ru) 2015-11-27
DK2944700T3 (en) 2018-01-22
CA2852850A1 (en) 2013-06-27
CN104651521A (zh) 2015-05-27
US20130102487A1 (en) 2013-04-25
US20180346996A1 (en) 2018-12-06
KR101900872B1 (ko) 2018-09-20
IN2015DN01855A (hu) 2015-07-10
JP2014530619A (ja) 2014-11-20
RU2662975C1 (ru) 2018-07-31
BR122015004941A2 (pt) 2019-08-20
NO3051026T3 (hu) 2018-07-28
PT2768986T (pt) 2018-10-23
WO2013093635A3 (en) 2013-09-06
JP6203209B2 (ja) 2017-09-27
AU2012356317B2 (en) 2016-04-07
US20150087525A1 (en) 2015-03-26
MX357119B (es) 2018-06-27
EP2944700A1 (en) 2015-11-18
KR20150036804A (ko) 2015-04-07
PT2944700T (pt) 2018-01-24
WO2013093635A2 (en) 2013-06-27
PL2944700T3 (pl) 2018-05-30
AU2012356317A1 (en) 2014-05-15
HUE035614T2 (hu) 2018-05-28
MX2014004810A (es) 2014-11-25
RU2611189C2 (ru) 2017-02-21
JP6159727B2 (ja) 2017-07-05
EP2768986A2 (en) 2014-08-27
US20150176082A1 (en) 2015-06-25
MX357550B (es) 2018-07-13
US20180355439A1 (en) 2018-12-13
CA2852850C (en) 2020-07-28
BR122015004941B1 (pt) 2021-09-28
EP2768986B1 (en) 2018-06-27
CN104145024A (zh) 2014-11-12

Similar Documents

Publication Publication Date Title
HUE039522T2 (hu) Plazma mikroRNS a végbélrák korai kimutatására
HK1198547A1 (en) Methods for detection of nucleotide modification
GB2505104B (en) Malware detection
IL219844A0 (en) Detection of tenting
EP2585833A4 (en) METHODS OF DETECTING CANCER
ZA201205135B (en) Liveness detection
EP2668295A4 (en) METHODS OF DETECTING LUNG CANCER
EP2707521A4 (en) IMPROVED MICROWAVE PLASMA ACTIVATORS
PL2788956T4 (pl) Wykrywanie laptopów
PT2876447T (pt) Método para deteção de cancro
EP2986326A4 (en) Methods for detecting cancer metastasis
PL2788755T3 (pl) Układ do detekcji hemolizy
PL2876446T3 (pl) Sposób wykrywania nowotworu
EP2707598A4 (en) PLASMA MICRO-THRUSTER
EP2988659A4 (en) Improved methods of cancer detection
EP2758777A4 (en) PROOF OF EGG CANCER
EP2786150A4 (en) DETECTION OF MULTIPLE ANALYTES
GB2510539B (en) Biomarkers of cancer
ZA201306693B (en) Molecular biomarker set for early detection of ovarian cancer
EP2771695A4 (en) METHOD OF DETECTION OF BREAST CANCERS
EP2782430A4 (en) APPARATUS FOR EVALUATING PLASMA
SI2639312T1 (sl) Imunski test za detekcijo miRNA
EP2643482A4 (en) EARLY DETECTION OF PANCREATIC CANCER
GB2503167B (en) Particle Detection
HK1191062A1 (zh) 用於檢測癌症的方法和化合物